501

Compound name
Quizartinib
Alt Name
AC220
AC010220
Vanflyta
Compound Image
Quizartinib.png
SMILES
O(CCN1CCOCC1)C=2C=C3C(N4C(S3)=NC(=C4)C5=CC=C(NC(NC=6C=C(C(C)(C)C)ON6)=O)C=C5)=CC2
MW
560.67
Brutto
C29H32N6O4S
InChI
InChI=1S/C29H32N6O4S/c1-29(2,3)25-17-26(33-39-25)32-27(36)30-20-6-4-19(5-7-20)22-18-35-23-9-8-21(16-24(23)40-28(35)31-22)38-15-12-34-10-13-37-14-11-34/h4-9,16-18H,10-15H2,1-3H3,(H2,30,32,33,36)
InChI Key
InChIKey=CVWXJKQAOSCOAB-UHFFFAOYSA-N
Approval Jurisdiction
2019 Japan, 2023 FDA
Approved for clinical use
Acute Myeloid Leukemia
CAS
950769-58-1
PubChem CID
24889392
Approved Drug List
1